معرفی
Prof. Rene Medema serves as Scientific Director at the Netherlands Cancer Institute (since 2012) and previously held roles including Professor of Experimental Oncology at UMC Utrecht (2005–2011) and Associate Professor in Hematology (1995–2001). His research focuses on cell cycle regulation, checkpoint recovery mechanisms, and spindle assembly dynamics. Key contributions include elucidating FoxO/FoxM1 roles in cell cycle transitions and discovering Plk-1's role in DNA damage checkpoint recovery. He leads a lab challenging conventional spindle force models and exploring cancer therapeutic strategies exploiting tumor cell instability.
- Education: Postdoctoral Research Fellow (1993–1995) at Whitehead Institute, MIT
Research interests span transcriptional control of cell division, oncogene regulation, and translational cancer biology. His work bridges basic cell biology with clinical oncology, emphasizing mechanisms of genomic instability in tumors.
- Awards: VICI Award (NWO 2004), EMBO Membership (2007), Academia Europaea (2012)
Advises research groups focused on checkpoint recovery and spindle dynamics. Lab collaborations explore therapeutic vulnerabilities in chromosome unstable cancers. Active in research leadership roles including managing education divisions at UMC Utrecht (2010–2011).
Led pioneering studies in forkhead transcription factors and Plk-1 biology, establishing his group as a global leader in cell cycle research. Current efforts integrate cellular mechanics with cancer therapy development.
